Retail price fixation of new drugs for 84 applications
Notification issued by the National Pharmaceutical Pricing Authority fixing the retail price of specified drug formulations under the Drugs (Prices Control) Order, 2013.
74 gazette notifications — Page 2 of 2
Notification issued by the National Pharmaceutical Pricing Authority fixing the retail price of specified drug formulations under the Drugs (Prices Control) Order, 2013.
Corrigendum issued by the National Pharmaceutical Pricing Authority correcting entries in notification S.O. 5493(E) dated 19th December 2024 regarding retail price fixation.
Extends the tenure of Shri Justice Anil Verma as Commissioner for the welfare of Bhopal gas leak disaster victims.
Amends several Quality Control Orders for specified fatty acids and oils, changing their effective date to October 24, 2025.
Notifies 26th September 2022 as the date of establishment of the Council under the National Institute of Pharmaceutical Education and Research Act, 1998.
Postpones enforcement of quality control for Vinyl Acetate Monomer and Methyl/Ethyl Acrylate to March 31, 2026.
Revises ceiling prices of scheduled formulations of Glucose and Sodium Chloride injections based on Wholesale Price Index (WPI) increase, effective April 1, 2025.
Revises ceiling prices of scheduled formulations based on annual Wholesale Price Index increase, effective from April 1, 2025, as per Drugs (Prices Control) Order, 2013.
Revises ceiling prices of scheduled drug formulations based on annual Wholesale Price Index increase of 1.74028% effective from 1.4.2025.
Fixes retail prices of eighty formulations of various pharmaceutical drugs as per the Drugs (Prices Control) Order, 2013.
Fixes ceiling prices for scheduled drug formulations based on annual Wholesale Price Index increase, effective April 1, 2025.
Fixes ceiling prices for scheduled formulations based on annual Wholesale Price Index increase as per the Drugs (Prices Control) Order, 2013.
Revises ceiling prices for Ringer Lactate injection formulations, effective April 1, 2025, based on a 1.74028% increase in the Wholesale Price Index.
Revises ceiling prices of coronary stents effective April 1, 2025, based on a 1.74028% wholesale price index adjustment for 2024.
Revises ceiling prices of Piperacillin and Tazobactam injections based on Wholesale Price Index increase, effective April 1, 2025, superseding previous order S.O. No. 1554(E) dated 26.03.2024.
Amends the enforcement date of the p-Xylene (Quality Control) Order, 2021 to December 19, 2025.
Amends enforcement date of Quality Control Orders for Beta Picoline, Sodium Tripolyphosphate, and Pyridine to March 13, 2026.
Amends the Ethylene Dichloride (Quality Control) Order, 2021, changing the enforcement date to September 12, 2025.
Fixes retail prices for various scheduled pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.
Corrects dosage form and strength of Azithromycin in Hindi version of Notification S.O. 659(E) regarding ceiling price revision.
This corrigendum revises the ceiling price of Synchrobreathe Inhaler, as previously notified under S.O. 5496(E) dated 19.12.2024.
Fixes/revises ceiling prices for scheduled formulations Azithromycin and Amoxicillin + Clavulanic acid under Drugs (Prices Control) Order, 2013, effective from notification date.
Fixes the retail price, excluding GST, of forty-two listed pharmaceutical formulations, exercising powers under the Drugs (Prices Control) Order, 2013.
Fixes the retail price of Cilnidipine & Telmisartan Tablets manufactured by M/s Akums Drugs & Pharmaceuticals Ltd. and M/s Glenmark Pharmaceuticals Limited.